In fact, phloretin is known to have an inhibitory effect on glucose transporter (GLUT) in human cancer cells (Wu et al., 2009), and therefore may simply compete with sugar transporters or other unknown T4 transporters. This evidence concerns the gene SLC2A1 and cancer.